Investors often face the challenge of balancing two distinct schools of analysis: fundamental, which assesses a company's intrinsic financial health and growth prospects, and technical, which examines price patterns and market psychology to time entries and exits. A strategy that joins these approaches seeks to identify companies with sound underlying business momentum that are also on the verge of a potential price breakout. This method aims to capture the upside of a strong growth story just as market sentiment starts to align, possibly leading to faster price appreciation. The goal is to find stocks where the fundamental engine is already running hot, and the technical chart is indicating that the market may be ready to re-price the stock higher.
One stock that recently appeared from a screen joining these criteria is HealthEquity Inc (NASDAQ:HQY). The company is a leading provider of technology-enabled services for healthcare spending decisions, primarily managing Health Savings Accounts (HSAs) and other consumer-directed benefits. In a landscape where healthcare costs and consumer financial responsibility are consistently rising, HealthEquity operates in a market with important structural tailwinds for growth.
A Strong Fundamental Growth Profile
The fundamental case for HealthEquity is persuasive, especially when evaluated through the lens of growth investing. The company's financial reports reveal a business that is not only getting larger but doing so with better efficiency. According to ChartMill's detailed fundamental analysis, HealthEquity earns a good overall rating of 6 out of 10, with its Growth and Profitability components standing out at a rating of 7 each.
- Impressive Revenue and Earnings Trajectory: The company has shown strong historical growth, with Revenue increasing by 17.66% on average annually over recent years and Earnings Per Share (EPS) growing by 12.72%. More importantly, this momentum is expected to continue. Analyst projections point to future EPS growth averaging 19.43% annually, signaling a quickening from the past trend.
- High Profitability Margins: HealthEquity operates with very good margins that do better than most of its peers in the Health Care Providers & Services industry. Its Profit Margin of 14.86% and Operating Margin of 23.20% are in the top group, pointing to a scalable and efficient business model that turns revenue into earnings well.
- Solid Financial Health: With a ChartMill Health rating of 7, the company keeps a sound balance sheet. Key strengths include a very strong Current Ratio and Quick Ratio above 4.0, signaling enough liquidity to meet short-term obligations. Its Debt/Equity ratio of 0.46 is viewed as healthy and manageable.
For a growth investor, these metrics are key. Strong, quickening earnings growth is the main fuel for long-term stock price appreciation. High profitability margins indicate the company has a competitive edge and pricing power, while a healthy balance sheet gives the stability to invest in future growth without high risk.
A Technical Setup Pointing to a Potential Breakout
While the fundamentals show a picture of a healthy, growing company, the technical analysis gives the context of its current market price action. ChartMill's technical report notes that while the overall technical rating is weak due to negative short and long-term trends, the stock shows a promising Setup Rating of 7 out of 10.
This higher setup score draws attention to a specific and possibly opportunistic chart pattern:
- Consolidation in a Range: After a large decline from its 52-week highs, HQY's price has been consolidating, trading between about $82.74 and $99.50 over the past month. This time of lower volatility and sideways movement often comes before a decisive new move.
- Key Support and Resistance Levels: The analysis finds a clear and important support zone around $83.01. A hold above this level could give a base for a move higher. On the other hand, immediate overhead resistance is noted near $86.42, with more important resistance clusters higher up.
- The Setup Opportunity: The current price is trading near the lower end of its recent range and close to the identified support. The "decent setup pattern" suggests that if the stock can hold support and break through nearby resistance, it could signal the start of a reversal, getting the notice of momentum traders and matching the technical picture with the strong fundamental story.
Growth, Quality, and Timing
The combination found in HealthEquity is what the screening method tries to find. The strong growth and profitability ratings meet the core idea of growth investing: finding companies with better expansion potential. The concurrent decent technical setup rating speaks to the challenge of timing. It suggests that after a time of price decline or consolidation, the stock may be setting up for its next move up, giving a more interesting entry point before a potential breakout.
This coming together does not promise success, but it methodically finds stocks where positive fundamental drivers and a helpful technical posture are present at the same time. It tries to avoid buying growth stocks that are technically overbought while also avoiding technically interesting charts supported by weak businesses.
Finding Similar Opportunities
HealthEquity acts as an example of a stock that meets specific criteria for strong growth joined with a helpful technical setup. For investors interested in using this joined fundamental and technical strategy to find other possible opportunities, more results can be found by looking at the Strong Growth Stock Technical Setups screen on ChartMill.
Disclaimer: This article is for informational and educational purposes only and does not form a recommendation to buy, sell, or hold any security. The analysis presented is based on data and reports given by ChartMill and should not be taken as investment advice. Investing in stocks involves risk, including the possible loss of principal. Always do your own complete research and think about your personal financial situation and risk tolerance before making any investment decisions.
